Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DO7MC9
|
|||
| Drug Name |
CD4CAR
|
|||
| Drug Type |
CAR T Cell Therapy
|
|||
| Indication | T-cell leukaemia [ICD-11: 2A90; ICD-10: C86] | Phase 1 | [1] | |
| Company |
iCell Gene Therapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03829540) CD4CAR for CD4+ Leukemia and Lymphoma. U.S. National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of iCell Gene Therapeutics. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.